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Abstract
Background: Phenolic compounds combine antioxidant and hypocholesterolemic activities and, consequently, are
expected to prevent or minimize cardiometabolic risk.
Methods: To evaluate the effect of an aqueous extract (AQ) and non-esterified phenolic fraction (NEPF) from
rosemary on oxidative stress in diet-induced hypercholesterolemia, 48 male 4-week old Wistar rats were divided
into 6 groups: 1 chow diet group (C) and 5 hypercholesterolemic diet groups, with 1 receiving water (HC),
2 receiving AQ at concentrations of 7 and 140 mg/kg body weight (AQ70 and AQ140, respectively), and 2 receiving
NEPF at concentrations of 7 and 14 mg/kg body weight (NEPF7 and NEPF14, respectively) by gavage for 4 weeks.
Results: In vitro, both AQ and NEPF had remarkable antioxidant activity in the 2,2-diphenyl-1-picrylhydrazyl (DPPH●)
assay, which was similar to BHT. In vivo, the group that received AQ at 70 mg/kg body weight had lower serum
total cholesterol (−39.8%), non-HDL-c (−44.4%) and thiobarbituric acid reactive substance (TBARS) levels (−37.7%)
compared with the HC group. NEPF (7 and 14 mg/kg) reduced the tissue TBARS levels and increased the activity of
tissular antioxidant enzymes (superoxide dismutase, catalase and glutathione peroxidase). Neither AQ nor NEPF was
able to ameliorate the alterations in the hypercholesterolemic diet-induced fatty acid composition in the liver.
Conclusions: These data suggest that phenolic compounds from rosemary ameliorate the antioxidant defense in
different tissues and attenuate oxidative stress in diet-induced hypercholesterolemic rats, whereas the serum lipid
profile was improved only in rats that received the aqueous extract.
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Background
Atherosclerosis is a chronic inflammatory disease initiated
by the subendothelial retention of low density lipoprotein
(LDL) particles followed by their subsequent oxidation.
The chemical modification of LDL particles induces the
expression of adhesion molecules, such as vascular cell ad-
hesion molecule-1 (VCAM-1) and intercellular adhesion
molecule-1 (ICAM-1), on endothelial cells and smooth
muscle cells, which, once activated, lead to cytokine secre-
tion and contribute to the recruitment of monocytes and
T cells to the arterial intima [1,2]. Macrophage colony-
stimulating factor (MCSF) induces monocytes entering the
plaque to differentiate into macrophages that display scav-
enger receptors on their surface. These receptors promote
modified LDL uptake in a process that is not regulated by
the intracellular lipid content, which ultimately leads to
foam cell formation. Therefore, hemodynamic stress and
the accumulation of lipids initiate an inflammatory process
in the artery wall [3,4].
Moreover, the accumulation of cholesterol in eryth-
rocytes, leukocytes, platelets and endothelial cells can
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lead to an increase in the concentration of reactive spe-
cies [5,6] and a reduction in the antioxidant defense
systems, such as catalase (CAT) glutathione peroxidase
(GPx) and superoxide dismutase (SOD) enzyme activities
[7]. This condition favors a disruption of the redox balance,
contributing to the establishment of oxidative stress, which
is involved in several metabolic disorders [8,9]. Thus,
substances that combine antioxidant and hypocholes-
terolemic activities are expected to prevent or attenuate the
cardiometabolic risk because the oxidative modification of
LDL and its uptake by macrophages present in the arterial
wall contribute to cardiovascular disease [10].
Phenolic compounds have been proven to be successful
in attenuating hypercholesterolemia [11-13]. Moreover,
these substances are known by their capacity to increase
antioxidant enzyme activity and reduce free radical forma-
tion, effects that have been of interest to researchers as
possible protective agents in diseases involving oxidative
stress [7,10,14]. Among the herbal extracts reported to have
antioxidant activity, rosemary (Rosmarinus officinalis L.) is
one of the most widely commercialized plant extracts; it
is used as a culinary herb for flavoring and as an antiox-
idant in processed foods and cosmetics [15]. Regarding
its antioxidant and anti-inflammatory activities, studies
have identified phenolic compounds obtained through
several extraction methods, mainly carnosic (phenolic di-
terpene) and rosmarinic acids (caffeic acid and 3,4-
dihidroxifenilactate ester) [16-18]. Although antioxidant
compounds have been demonstrated to have beneficial
effects on some parameters related to the cardiovascular
risk, the role of rosemary phenolic compounds on
hypercholesterolemia-induced oxidative stress has not been
elucidated in the literature. Therefore, the aim of this study
was to evaluate the effect of two different extracts, an aque-
ous extract and a non-esterified phenolic fraction, from
rosemary (Rosmarinus officinalis L.) on the antioxidant
status of the serum and tissues from diet-induced hyper-
cholesterolemic rats.
Methods
Preparation of the aqueous extract and non-esterified
phenolic fraction
Dried and powdered rosemary leaves (20 g) were extracted
with distilled water (100 mL) at room temperature (23°C)
for 1 h. The samples were centrifuged at 15,000 rpm for
10 min. The supernatant was filtered through qualitative
filter paper, and distilled water was added to a total vol-
ume of 100 mL. The non-esterified phenolic fraction was
obtained by homogenizing powdered, defatted rosemary
leaves (1 g) with tetrahydrofuran (6 successive one-minute
periods with 20 mL) at room temperature [19]. The super-
natant was filtered with sodium sulfate anhydrous and
vacuum-evaporated to dryness at 30°C. The dried mass
was then resuspended in 5 mL of methanol and filtered
through qualitative filter paper into a 5 mL volumetric
flask, and methanol was added to achieve the final volume
of 20 mL. The solutions were kept at −20°C until further
analysis.
Determination of total phenolic content
The total phenolics were determined by the Folin-
Ciocalteau method [20]. The total phenolic content was
expressed as milligrams of gallic acid equivalent (GAE)
per gram of leaf.
High performance liquid chromatography (HPLC) analysis
Rosmarinic and carnosic acids were identified and quan-
tified by a modified version of the method described by
Almela et al. [21] using HPLC with UV/Vis detection
and a reversed-phase Luna C18 column (250 x 4.3 x 10 μm,
Phenomenex, USA). The mobile phase consisted of 0.2%
metaphosphoric acid (A) and acetonitrile (B) using a gra-
dient program of 0–20 min 80% A, 20–30 min 60% A, and
30–40 min 0% A. The flow rate was 1 mL/min. The peaks
for rosmarinic and carnosic acids, which have detection
limits of 1.58 μg/mL and 1.46 μg/mL, respectively, were
detected at 330 and 230 nm, respectively. The peaks were
identified by comparing their retention times with those of
standards (Sigma Aldrich, St Louis, MO, USA), which were
run individually. Carnosic and rosmarinic acid calibration
curves (R2 = 0.999 for both) were used for quantification.
Determination of in vitro antioxidant activity using the
β-carotene/linoleic acid system and DPPH● assay
The β-carotene/linoleic acid co-oxidation system was
conducted as previously described [22]. The antioxidant
activity of the samples was also assessed by the 2,2-
diphenyl-1-picrylhydrazyl (DPPH●) radical method [23].
The results were expressed as μmol equivalents BHT/g
of sample.
Table 1 Composition of the experimental diets (g/kg diet)a
Parameters (g/kg diet) Chow diet Hypercholesterolemic diet
Protein 220 220
Lipids 40 40
Fiber 80 80
Mineral mix* 100 100
Carbohydrates 560 560
Cholesterol 0 5
Cholic acid 0 2.5
a NuvilabW CR-1, Nuvital, BRA.
*Mineral mix: Iron 50 mg; zinc 60 mg; copper 10 mg; iodine 2 mg;
manganese 60 mg; selenium 0.05 mg; cobalt 1.50 mg.
Vitamin Mixture provided the following amounts (per kg of diet): Vitamin
A 12,000 UI; vitamin E 30 mg; vitamin K 3 mg; B vitamins 18 mg, niacin 60 mg;
pantothenic acid 20 mg; folic acid 1 mg; biotin 0.05 mg, choline 600 mg.
Diets were isoenergetic (15 MJ/kg of diet) and given in pellet form.
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Animals and diet
Male Wistar rats (Rattus norvegicus, var. albinus) (101.3 ±
0.4 g) were obtained from the Animal Laboratory of the
Faculty of Pharmaceutical Sciences at the University of
São Paulo. A total of forty-eight rats (n = 8 per group, 4
weeks old) were kept in a room at an ambient tem-
perature of 22 ± 2°C and a relative humidity of 55 ± 10%
under a 12-h light/12-h dark cycle (lights on at 0700 h).
All procedures performed on animals were approved by
the Ethics Committee on Animal Experimentation of the
Faculty of Pharmaceutical Sciences, University of São
Paulo (protocol number 174/2008), according to the
guidelines of the Brazilian College on Animal Experimen-
tation. The animals were randomly distributed into six
groups: C (chow diet, receiving distilled water), HC
(hypercholesterolemic diet, receiving distilled water), AQ
70 and 140 (hypercholesterolemic diet, treated with 70
and 140 mg aqueous extract/kg body weight/d, respec-
tively), and NEPF 7 and 14 (hypercholesterolemic diet,
treated with 7 and 14 mg of non-esterified phenolic frac-
tion/kg body weight/d, respectively).
To induce hypercholesterolemia, the chow diet (AIN-
93M NuvilabW CR-1, Nuvital, BRA) was enriched with
0.5% cholesterol and 0.25% cholic acid (Sigma Aldrich)
(Table 1). Food and water were provided ad libitum
throughout the experiment. The aqueous extract, non-
esterified phenolic fraction and distilled water were
administered daily by gavage (0.5 mL/100 g body weight)
during the light cycle (at 1300 h) for 4 weeks. Food con-
sumption and weight were monitored daily throughout
the experiment. After 4 weeks, the rats were deprived
of food for 12 hours and anesthetized with ketamine
(90 mg/kg, Vetbrands, BRA) and xylazine (10 mg/kg,
Vetbrands, BRA). All of the animals were killed in the
morning between 08:00 a.m. and 12:00 p.m. The tissues
were perfused with saline (0.9% w/v), collected and imme-
diately frozen. The blood was collected from the abdom-
inal aorta, and serum was obtained by centrifugation at
3,500 rpm at 4°C for 5 minutes. The serum and tissues
were stored at −80°C until further analysis.
Extraction and esterification of hepatic lipids
Lipids from the hepatic tissue were obtained by the
Folch method [24], and the fatty acid methyl ester con-
tent was determined according to the American Oil
Chemists Society method Ce 2–66 [25].
Fatty acid profile of hepatic tissue
The samples were analyzed by gas chromatography
(Shimadzu, GC 17A, Kyoto, JAP) using a fused silica
capillary column (100 m × 0.25 mm, SP-2560). After a
5 minute isothermal period, the temperature of the col-
umn was increased from 140°C to 240°C at a rate of
4°C/min and then kept constant for 20 minutes. The in-
jector and detector temperatures were 250°C and 260°C,
respectively. Helium was employed as the carrier gas at
a flow rate of 1 mL/min, and a sample volume of 1 μL
was injected at a split ratio of 1:200. The peaks were
identified by comparing their retention times with those
of the standards (Supelco 18919, USA), which were run
at a split ratio of 1:50.
Activity of tissue antioxidant enzymes
The tissular catalase (CAT), superoxide dismutase (SOD)
and glutathione peroxidase (GPx) activities were deter-
mined as described by Beutler [26], McCord and Fridovich
Table 2 In vitro antioxidant activity of the aqueous
extract and non-esterified phenolic fraction of rosemary
Samples β-carotene/linoleic acid system DPPH●
antioxidant activity μmol BHT/g sample
Aqueous Extract 500 μg 1000 μg
113.25 ± 4.55A 118.03 ± 3.88A 4601.29 ± 60.54A
Non-Esterified
Phenolic Fraction
50 μg 100 μg
929.35 ± 49.88B 1035.00 ± 21.21B 4752.80 ± 190.09A
Butylated hydroxytoluene (BHT) antioxidant activity = 4538.00 μmol/g.
The results are expressed as the means ± S.E.M. (n = 3).
Table 3 Weight gain, food intake, food efficiency ratio (FER) and lipid profile of the experimental groups
C HC AQ 70 AQ 140 NEPF 7 NEPF 14
Weight Gain (g) 167.64 ± 13.41 179.21 ± 24.13ª 175.95 ± 16.22ª 174.06 ± 25.68ª 175.53 ± 17.75ª 179.67 ± 24.71ª
Food intake (g/day) 20.24 ± 2.82 21.85 ± 3.77ª 21.52 ± 3.38ª 21.32 ± 3.20ª 21.79 ± 3.53ª 22.05 ± 4.63ª
FER 0.38 0.37 0.37 0.37 0.37 0.39
TC (mg/dL) 61.30 ± 6.46 178.54 ± 33.31ª* 107.47 ± 32.42b 128.85 ± 23.71ab 139.01 ± 38.25a 143.01 ± 37.92a
Non-HDL-c (mg/dL) 26.46 ± 1.76 152.00 ± 14.67ª* 84.47 ± 12.78b 103.70 ± 10.03ab 120.60 ± 17.46a 127.20 ± 18.59a
HDL-c (mg/dL) 38.15 ± 6.49 21.36 ± 3.47ª* 25.04 ± 2.57ª 25.28 ± 2.24ª 21.42 ± 3.71ª 21.04 ± 2.10ª
TG (mg/dL) 25.34 ± 7.75 30.25 ± 7.76ª 26.25 ± 5.28ª 23.92 ± 4.68ª 26.13 ± 4.57ª 30.27 ± 4.63ª
C (normocholesterolemic group), HC (hypercholesterolemic group), AQ 70 (HC + aqueous extract 70 mg/kg), AQ 140 (HC + aqueous extract 140 mg/kg),
NEPF 7 (HC + non-esterified phenolic fraction 7 mg/kg), NEPF 14 (HC + non-esterified phenolic fraction 14 mg/kg).
The results are expressed as the means ± S.E.M (n = 5-8).
Different letters represent significant differences between rows (Tukey-Kramer test, p < 0.05), * significant difference between normocholesterolemic
(C) vs hypercholesterolemic (HC) groups by Student’s t test (p < 0.05).
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[27] and Sies et al. [28], respectively. All analyses were
conducted using a spectrophotometer, and absorbances
were monitored every 60 seconds for 6 minutes.
Protein quantification
A spectrophotometric method [29] was used to determine
the protein content in the serum and tissues analyzed.
Determination of thiobarbituric acid-reactive substances
(TBARS)
The method described by Ohkawa et al. [30] was employed.
The absorbance was measured at 532 nm on a spectropho-
tometer. The TBARS concentrations were calculated using a
standard curve for 1,10,3,30-(TEP) tetraethoxypropane (10-4
mol/L) and were expressed as μmol of malondialdehyde
(MDA) per milligram of protein.
Serum lipids
The serum total cholesterol (TC), triacylglycerol (TG), and
high density lipoprotein cholesterol (HDL-c) levels were
assessed using commercial enzymatic colorimetric kits
(LabtestW, BRA). The non-high-density lipoprotein choles-
terol (non-HDL-c) levels were calculated by subtracting
the HDL-c levels from the total cholesterol levels [31].
Statistical analysis
Statistical analyses were conducted using GraphPad Prism
4.0 for Windows (San Diego, CA, USA). The collected data
were subjected to the Kolmogorov-Smirnov test to check
for symmetry. The data were expressed as the mean and
standard error, and the significance level was set at 0.05.
Student’s t test was used to compare two independent
samples (the C and HC groups). Three or more indepen-
dent samples (treated or non-treated HC groups) were
compared using a one-way analysis of variance (ANOVA)
and Tukey’s test (p < 0.05).
Results
Characterization of the aqueous extract and non-
esterified phenolic fraction from Rosmarinus officinalis
The total phenolic content in the extracts was 16.67 ± 0.40
mg GAE/g leaf in the AQ and 8.59 ± 0.31 mg GAE/g leaf in
the NEPF. Regarding the major compounds, 1.87 ± 0.02 g
Figure 1 TBARS concentrations (μmol MDA/mg protein) in the
serum, heart, kidneys, brains and liver. C (normocholesterolemic
group), HC (hypercholesterolemic group), AQ 70 (HC + aqueous
extract 70 mg/kg), AQ 140 (HC + aqueous extract 140 mg/kg),
NEPF 7 (HC + non-esterified phenolic fraction 7 mg/kg), NEPF 14
(HC + non-esterified phenolic fraction 14 mg/kg). The results are
expressed as the means ± S.E.M; n = 5–8. Different letters represent
significant differences between groups (Tukey-Kramer test, p < 0.05).
* p < 0.05 normocholesterolemic (C) vs hypercholesterolemic
(HC) groups by Student’s t test.
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of rosmarinic acid/100 g dry weight was detected in the
AQ, and 5.71 ± 0.05 g of carnosic acid/100 g dry weight
was detected in the NEPF; these levels are consistent with
the results from other studies [18]. The antioxidant poten-
tial of the rosemary extracts were evaluated using the
DPPH● method, yielding 4601.29 ± 60.54 and 4752.80 ±
190.09 μmol BHT equivalents/g for the AQ and NEPF, re-
spectively. All values were comparable with the BHTactiv-
ity (4538.00 μmol/g), confirming that both extracts
possess the hydrogen-donating capability to act as an anti-
oxidant (Table 2). In the β-carotene-linoleate model sys-
tem, AQ at 500 and 1000 μg showed an antioxidant activity
of 113.25 ± 4.55 and 118.03 ± 3.88 μmol BHT equivalents/g,
respectively. However, the antioxidant activity obtained with
NEPF at 50 and 100 μg was approximately 10 times higher
than the aqueous extract effect (929.35 ± 49.88 and 1035 ±
21.21 μmol BHT equivalents/g, respectively).
Body weight, food intake and weight gain
The in vivo experiments showed that the mean values of
weight gain and food intake were not significantly differ-
ent among the groups and therefore the food efficiency
ratio (FER) was similar (Table 3), suggesting that the
phenolic compounds present in rosemary did not impair
the nutrient intake (Table 3).
Effect of the aqueous extract and non-esterified phenolic
fraction on serum lipids
The TC and non-HDL-c levels were increased in the
serum of rats submitted to a hypercholesterolemic diet
(HC group) compared with the normocholesterolemic
(C) group (p < 0.001). These results are similar to those
reported in the literature using the same experimental
model [10,13]. Moreover, the HC group had lower
serum levels of HDL-c than the C group (p < 0.001,
Table 3). Although both concentrations of the NEPF
did not have a significant effect on the serum lipid pro-
file, the AQ at 70 mg/kg significantly reduced the
serum TC and non-HDL-c levels by 39.8% (p < 0.01)
and 44.4% (p < 0.05), respectively, compared with the
HC group but showed no effects on the TG and HDL-c
levels. The AQ at a higher concentration (140 mg/kg
body weight) did not result in any substantial reduction
in the serum TC and non-HDL-c levels (p > 0.05 AQ70
vs AQ140, Table 3).
Effect of the aqueous extract and non-esterified phenolic
fraction on thiobarbituric acid reactive substances (TBARS)
In addition to an effect on the lipid profile, AQ at 70 mg/kg
body weight was also able to significantly reduce the serum
TBARS levels from 1.34 to 0.83 μmol MDA/mg protein
compared with the untreated hypercholesterolemic rats
(Figure 1a). Regarding the tissue TBARS levels, an increase
in lipid peroxidation was observed in the HC group
compared with the normocholesterolemic group in the
heart and kidneys (Figure 1b and c, respectively). The NEPF
at 7 and 14 mg/kg was able to reduce the TBARS levels in
the heart (24.32% and 16.05%, respectively) and renal
tissues (33.61 and 27.29%, respectively).
In the brain and liver (Figure 1d and e, respectively),
no difference was observed in the HC group compared
with the C group. However, the AQ and NEPF groups
notably showed lower TBARS levels compared with the
HC group in these tissues.
Activity of antioxidant enzymes
Although the liver CAT activity was significantly lower
in the HC rats than in the C rats (226.30 ± 20.68 vs
382.60 ± 21.88 U/mg protein), the oral administration of
both phenolic extracts from rosemary at the lower con-
centration was able to significantly increase (p < 0.05)
the CAT activity, and this effect was more prominent
with the higher concentration (p < 0.001), thereby
showing a dose–response effect (Figure 2a). With re-
spect to GPx, only the highest concentration of the AQ
was able to significantly increase the activity of this
Figure 2 Activity of the antioxidant enzymes catalase (a), glutathione peroxidase (b) and superoxide dismutase (c) in the liver.
C (normocholesterolemic group), HC (hypercholesterolemic group), AQ 70 (HC + aqueous extract 70 mg/kg), AQ 140 (HC + aqueous extract
140 mg/kg), NEPF 7 (HC + non-esterified phenolic fraction 7 mg/kg), NEPF 14 (HC + non-esterified phenolic fraction 14 mg/kg). The results are
expressed as the means ± S.E.M; n = 5–8. Different letters represent significant differences between groups (Tukey-Kramer test, p < 0.05). * p < 0.05
normocholesterolemic (C) vs hypercholesterolemic (HC) groups by Student’s t test.
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enzyme (Figure 2b). However, no effect was observed for
SOD activity in either of the treatments (Figure 2c). As
observed in the hepatic tissue, the CAT activity in the
kidneys of the HC group was significantly lower than in
the C group, but the NEPF increased the CAT and SOD
activities at both concentrations (Figure 3a and c, re-
spectively). In cardiac tissue, none of the antioxidant
enzymes presented a difference in their activities among
the C and HC groups (p > 0.05). The AQ did not exert a
significant effect on the activities of the antioxidant
enzymes. In contrast to the data obtained from the
kidneys, NEPF was not able to increase the SOD and
CAT cardiac activities (Figure 4a and c, respectively).
The hypercholesterolemic group had a significant de-
crease in the SOD and GPx activities, indicating oxida-
tive damage in the brain. As observed in the liver, only
the highest AQ concentration was able to increase the
activities of the above enzymes (p < 0.001). The NEPF
did not raise the GPx activity (Figure 5b) but was able to
increase the SOD activity (14.45% for 7 mg/kg and
18.41% for 14 mg/kg, p < 0.001).
Fatty acid profile of hepatic tissue
Table 4 shows that the hypercholesterolemic diet
increased the total lipids and led to a modification of the
lipid composition in the liver, as previously reported [6,32].
No significant difference in the amount of total lipids,
SAFA, MUFA and PUFA was observed between the treated
and untreated hypercholesterolemic groups. However,
a reduction in the amount of saturated fatty acids (SAFA,
p < 0.001) and an increase in monounsaturated fatty
acids (MUFA, p < 0.001) occurred in the hypercholes-
terolemic group compared with the normocholesterolemic
group (Table 4).
Discussion
In this investigation, we performed in vivo experiments
that showed that only AQ 70 was capable of significantly
reducing the serum TC and non-HDL-c levels in diet-
induced hypercholesterolemic rats, as demonstrated in
Table 3. This effect may be attributed to the higher
amount of total phenolic compounds found in AQ,
which was almost twice as much as in NEPF, which
Figure 4 Activity of the antioxidant enzymes catalase (a), glutathione peroxidase (b) and superoxide dismutase (c) in the heart.
C (normocholesterolemic group), HC (hypercholesterolemic group), AQ 70 (HC + aqueous extract 70 mg/kg), AQ 140 (HC + aqueous extract
140 mg/kg), NEPF 7 (HC + non-esterified phenolic fraction 7 mg/kg), NEPF 14 (HC + non-esterified phenolic fraction 14 mg/kg). The results are
expressed as the means ± S.E.M; n = 5–8. Different letters represent significant differences between groups (Tukey-Kramer test, p < 0.05). * p < 0.05
normocholesterolemic (C) vs hypercholesterolemic (HC) groups by Student’s t test.
Figure 3 Activity of the antioxidant enzymes catalase (a), glutathione peroxidase (b) and superoxide dismutase (c) in the kidneys.
C (normocholesterolemic group), HC (hypercholesterolemic group), AQ 70 (HC + aqueous extract 70 mg/kg), AQ 140 (HC + aqueous extract
140 mg/kg), NEPF 7 (HC + non-esterified phenolic fraction 7 mg/kg), NEPF 14 (HC + non-esterified phenolic fraction 14 mg/kg). The results are
expressed as the means ± S.E.M; n = 5–8. Different letters represent significant differences between groups (Tukey-Kramer test, p < 0.05). * p < 0.05
normocholesterolemic (C) vs hypercholesterolemic (HC) groups by Student’s t test.
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represented a more purified fraction. This result suggests
that other phenolic compounds, beyond those found in
the NEPF, may be responsible for these responses. This
effect on cholesterol reduction may be attributed to a
decrease in the micellar solubilization of cholesterol in
the digestive tract, to an increase in bile flow, bile cho-
lesterol and bile acid concentration and to a subsequent
increase in the fecal excretion of steroids, as previously
described [33,34].
This study showed that both extracts (AQ70, AQ140)
obtained from rosemary decreased the tissue TBARS
levels, lowering the susceptibility to the peroxidative
damage elicited by a cholesterol-rich diet. This effect
could be attributed to the antiradical activity of these
extracts, as demonstrated by the DPPH● assay. In this
context, AQ70 could contribute to a decrease in the
CVD risk because it simultaneously reduced the TBARS
levels and improved the plasma lipid contents.
This protection could be attributed to rosmarinic acid,
which has been reported to inhibit the expression of in-
ducible nitric oxide synthase (iNOS) and suppress the
production of superoxide and 3-nitrotyrosine in Raw
264.7 macrophages [35].
Notably, oxidative stress is characterized by not only
increased free radical production but also reduced anti-
oxidant enzyme activities [7]. In fact, we observed that
animals submitted to a high cholesterol diet plus water
presented lower catalase activity in their hepatic and
renal tissues (Figures 2a and 3a, respectively) compared
with the animals receiving only a chow diet. An impor-
tant observation from this study was that the phenolic
compounds from rosemary were able to reestablish cata-
lase activity, as observed with the AQ and NEPF in the
Table 4 Fatty acid composition (g/100 g fatty acids) of liver
C HC AQ 70 AQ 140 NEPF 7 NEPF 14
C16:0 20.36 ± 1.96 13.77 ± 0.54ab* 13.84 ± 0.36ab 14.76 ± 1.52b 13.11 ± 0.51a 12.58 ± 0.59a
C18:0 18.27 ± 2.22 7.20 ± 1.28* 6.66 ± 0.58 6.10 ± 1.00 6.22 ± 0.95 6.24 ± 0.84
Total SAFA 39.87 ± 3.13 21.49 ± 1.67a* 20.90 ± 0.73ab 21.39 ± 1.63a 20.59 ± 1.43ab 19.14 ± 0.88b
C16:1 0.64 ± 0.37 3.57 ± 0.85ab* 3.17 ± 0.60a 2.74 ± 0.47a 3.76 ± 0.79ab 3.57 ± 0.61b
C18:1 11.75 ± 4.20 25.12 ± 1.78* 25.47 ± 1.12 26.18 ± 1.66 25.50 ± 1.93 26.37 ± 1.73
Total MUFA 12.48 ± 4.66 29.38 ± 2.48* 29.14 ± 1.73 29.23 ± 1.77 29.76 ± 2.69 30.37 ± 1.96
C18:2 20.29 ± 3.79 31.42 ± 0.85* 32.33 ± 0.77 32.08 ± 2.05 31.57 ± 1.47 32.30 ± 1.26
Total PUFA 45.85 ± 6.55 47.54 ± 1.08 49.20 ± 1.19 48.59 ± 2.34 47.77 ± 1.89 48.05 ± 1.96
C18:1/C18:0 0.64 3.49 3.82 4.29 4.10 4.23
Total lipids (mg) 11.71 ± 2.51 25.06 ± 5.46* 26.09 ± 4.62 28.13 ± 3.56 25.77 ± 4.93 26.49 ± 1.65
C (normocholesterolemic group), HC (hypercholesterolemic group), AQ 70 (HC + aqueous extract 70 mg/kg), AQ 140 (HC + aqueous extract 140 mg/kg), NEPF 7
(HC + non-esterified phenolic fraction 7 mg/kg), NEPF 14 (HC + non-esterified phenolic fraction 14 mg/kg).
SAFA: Saturated Fatty Acids; MUFA: Monounsaturated Fatty Acids; PUFA: Polyunsaturated Fatty Acids.
The results are expressed as the means ± S.E.M (n = 5-8).
Different letters represent significant differences between groups (Tukey-Kramer test, p < 0.05).
* significant difference between normocholesterolemic (C) vs hypercholesterolemic (HC) groups by Student’s t test (p < 0.05).
Figure 5 Activity of the antioxidant enzymes superoxide
dismutase (a) and glutathione peroxidase (b) in the brain.
C (normocholesterolemic group), HC (hypercholesterolemic group),
AQ 70 (HC + aqueous extract 70 mg/kg), AQ 140 (HC + aqueous
extract 140 mg/kg), NEPF 7 (HC + non-esterified phenolic fraction
7 mg/kg), NEPF 14 (HC + non-esterified phenolic fraction 14 mg/kg).
The results are expressed as the means ± S.E.M; n = 5–8.
Different letters represent significant differences between groups
(Tukey-Kramer test, p < 0.05). * p < 0.05 normocholesterolemic (C) vs
hypercholesterolemic (HC) groups by Student’s t test.
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liver and with the NEPF in the kidney. Data from the lit-
erature demonstrated that carnosic acid (found in NEPF)
increased the antioxidant enzyme activities and inhibited
lipid peroxidation in Caco-2 cells [36]. In kidneys, AQ70
also increased the GPx activity, which could be an adaptive
process to cope with the free radical production (Figure 1c).
However, AQ140 promoted a significant increase in the
SOD activity (p < 0.05), similar to that observed for phen-
olic extracts from olive mill wastewater in which the anti-
oxidant properties were only observed when administered
at a higher concentration [10].
Both extracts (AQ and NEPF) at different concentrations
were not able to increase the antioxidant enzyme activities
in the cardiac tissue of the animals studied. Moreover,
NEPF (7 mg/kg body weight) reduced the SOD and CAT
activities. Bouderbala et al. [37] have also reported a reduc-
tion in SOD activity in the kidneys of hypercho-
lesterolemic animals fed on a high cholesterol diet
supplemented with Ajuga iva (0.5%). The observed effect
was attributed to the lack of superoxide anion accumula-
tion in these tissues. Extrapolating these results to our
study, we can infer that the phenolic constituents of NEPF
may have reduced the concentration of superoxide anions
in the cardiac tissue, thereby reducing the need to activate
the antioxidant enzymes.
The HC group had a significant decrease in the SOD
and GPx activities, indicating oxidative stress in the
brain. As observed for the kidneys, only the highest AQ
concentration was able to increase the activities of these
enzymes (p < 0.05), whereas NEPF was able to increase
the SOD activity (14.95% for 7 mg/kg and 17.95% for
14 mg/kg, P < 0.05). A recent study showed that pre-
treatment with an aqueous extract from a plant also
belonging to the Lamiaceae family was able to reduce
the cerebral infarct size and lipid peroxidation [38].
These protective effects involve the permeability of
phenolic compounds across the blood–brain barrier,
which has been demonstrated in both in vitro and in situ
models [39,40].
Cholesterol-enriched diets also favor liver fat depo-
sition, which plays a role in lipoprotein synthesis and
metabolism and therefore in the cardiovascular disease
risk [6,41]. In the present study, the increase in the total
lipids and modification of the lipid composition in the
HC group may be attributed to the higher stearoyl-CoA
desaturase (SCD) activity elicited by cholesterol- and
cholic acid-containing diets. In fact, in our study all
animals fed on a hypercholesterolemic diet exhibited a
higher oleic-to-stearic-acid ratio compared with the con-
trol group, which suggests a higher SCD activity as
demonstrated in another study performed with the same
animal model [42]. This effect may be a protective mech-
anism as SCD can convert saturated into monounsaturated
fatty acids, which are preferred substrates for acyl-CoA:
cholesterol acyltransferase (ACAT), an enzyme that cat-
alyzes the esterification of hepatic free cholesterol to an
inert cholesteryl ester [43]. However, no significant dif-
ferences between the treated and untreated hypercho-
lesterolemic groups were observed with respect to hepatic
lipids. In this context, the effects of the phenolic com-
pounds from rosemary on the lipoprotein levels can be
suggested to be especially related to intestinal cholesterol
absorption.
Conclusion
In conclusion, our results suggest that phenolic com-
pounds from Rosmarinus officinalis protect against
hypercholesterolemia-induced oxidative stress, increas-
ing the activities of antioxidant enzymes and reducing
the amount of thiobarbituric acid reactive substances.
The aqueous extract was also able to improve the serum
lipid profile, contributing to cardiovascular disease re-
duction. Future analysis involving the bioavailability of
rosemary phenolic compounds and their role on modu-
lating the signaling pathways activated under oxidative
stress-related diseases may help to clarify the role of
these antioxidant compounds in cholesterol homeostasis
and parameters of oxidative stress.
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